Farshid Guilak, PhD, named Kappa Delta Elizabeth Winston Lanier Award recipient for research in functional cartilage engineering for total joint resurfacing
News provided by
Share this article
Share this article
ROSEMONT, Ill., Feb. 12, 2021 /PRNewswire/ The 2021 Kappa Delta Elizabeth Winston Lanier Award was presented to Farshid Guilak, PhD and his co-authors, Bradley T. Estes, PhD, and Franklin T. Moutos, PhD, for their research and development of technology to grow bioartificial cartilage using a patient s own donor cells and seeding them on a novel scaffold that can be molded to match the shape of a patient s joint. Following a successful preclinical trial on canines with hip osteoarthritis (OA), the research is soon expected to begin a Phase I clinical trial. Additionally, Dr. Guilak s work in gene therapy to protect against joint inflammation has the potential to advance the treatment of patients with arthritis and some orthopaedic conditions. The Kappa Delta Awards recog
American Academy Of Orthopaedic Surgeons Bestows Kappa Delta Award For Excellence In Orthopaedic Research To Cytex Founding Scientists
News provided by
Share this article
Share this article
DURHAM, N.C., Feb. 12, 2021 /PRNewswire/ The American Academy of Orthopedic Surgeons (AAOS) today announced that the 2021 Kappa Delta Elizabeth Winston Lanier Award has been granted to Cytex Therapeutics founders Drs. Farshid Guilak, Bradley Estes and Frank Moutos. The Kappa Delta Awards recognize research in musculoskeletal disease or injury with potential to advance patient care and are the highest awards in the field of orthopaedic research. The aim of their research was developing a way to effectively restore damaged cartilage that leads to osteoarthritis in the hip, knee and other joints in the body. This work led to forming Cytex Therapeutics and development of implants that Cytex plans to take into clinical studies later this year.
Here s how osteoporosis treatment got affected by COVID-19 pandemic ANI | Updated: Feb 10, 2021 10:45 IST
Bern [Switzerland], February 10 (ANI): A worldwide survey of medical care providers by the International Osteoporosis Foundation (IOF), the National Osteoporosis Foundation (NOF), and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (ESCEO) has uncovered uncommon impacts of the Covid-19 pandemic on overall medical care conveyance for osteoporosis.
Osteoporosis is a chronic, age-related disease that is associated with life-changing fragility fractures. Approximately 740,000 people lose their lives following hip fractures every year.
The survey report is based on online questionnaires completed from April to June 2020 by 209 healthcare providers in 53 countries: 28% from Europe, 24% from North America, and 19%, 17%, and 12% from the Asia-Pacific, the Middle East, and Latin